Abbott Laboratories (NYSE:ABT) agreed to acquire Exact Sciences for US$21b. The deal is set to reshape Abbott’s diagnostics business by adding a broad cancer testing platform. Management is also rolling out changes in the Nutrition segment in response to ongoing operational challenges. For you as an investor, the Exact Sciences deal puts a spotlight on Abbott’s push deeper into cancer diagnostics, an area that continues to attract significant attention across healthcare. At the same time,…
Abbott’s Exact Sciences Deal Recasts Diagnostics While Nutrition Faces Reset
Latest from Blog
Nutrition Experts Expose The Healthy Habits That Aren’t Healthy At All
“In many countries the word ‘organic’ is legally meaningless. Again, if it is not legally required to be on the packaging then it is a sales tactic.” Post Views: 2
Finnish sports-nutrition firm Elite Fitness gets new owner
Finland-based sports nutrition company Elite Fitness has a new majority shareholder. Post Views: 2
Spain’s Alimentos Sanygran buys assets from Nutrition & Santé
The Spanish firm said the deal will help in “further consolidating” its position in the development of plant-based foods. Post Views: 2
Intermittent fasting maintains long-term weight loss, regardless of meal timing, study shows
A team of scientists from the University of Granada (UGR), the Granada Institute for Biomedical Research (ibs.GRANADA), the Public University of Navarra and the Biomedical Research Networking Center (CIBER) … Post Views:
Novella’s bioreactor brings consistency and climate resilience to botanical ingredients
Novella Innovative Technology is seeking to address issues in the nutrition and food sectors by improving supply chain and ingredient consistency with precision botanicals. Nutrition Insight speaks with Itay Dana, co-founder and CMO